Relmada Therapeutics, Inc. (RLMD)
4.15
-0.05
(-1.19%)
USD |
NASDAQ |
Feb 10, 10:29
Relmada Therapeutics Price : 4.15 for Feb. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.30 |
| Invivyd, Inc. | 1.495 |
| Arcellx, Inc. | 67.55 |
| ACADIA Pharmaceuticals, Inc. | 23.20 |
| Alnylam Pharmaceuticals, Inc. | 321.13 |
Price Related Metrics
| Price to Book Value | 32.15 |
| Earnings Yield | -43.30% |
| Market Cap | 304.33M |